DEVIANCE AND EARLY SCHOOL LEAVING: STRATEGIES FOR AN INCLUSIVE SCHOOL
Giornale Italiano di Educazione alla Salute, Sport e Didattica Inclusiva · 01.01.2023
DOI: 10.32043/gsd.v7i2.851 ↗Kurz gefasst
Fachartikel in der Zeitschrift Giornale Italiano di Educazione alla Salute, Sport e Didattica Inclusiva, erschienen am 01.01.2023. Verfasst von Diletta Chiusaroli und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Youth distress turns into deviance when the adolescent's actions go beyond social norms and self-respect, when in imagining possibilities for the future he sees no alternative other than harmful behavior toward himself and others. Phenomena such as social exclusion, situations of vulnerability and marginality along with conditions of cultural impoverishment contribute to increasing phenomena such as school dropout. The basic task of the school is to prevent and offer responses to the main problems that are configured as an obstacle to a person's full development, with regard also to the phenomena of bullying and cyberbullying. Starting from these considerations, the aim of this paper is to analyze critical issues related to the education of fragile subjects and implement an analysis of the main teaching strategies aimed at inclusion and countering early school leaving.
Schlagwörter
Zitieren
APA
Chiusaroli, D., & Vito, L. D. (2023). DEVIANCE AND EARLY SCHOOL LEAVING: STRATEGIES FOR AN INCLUSIVE SCHOOL. Giornale Italiano di Educazione alla Salute, Sport e Didattica Inclusiva. https://doi.org/10.32043/gsd.v7i2.851
Vancouver
Chiusaroli D, Vito LD. DEVIANCE AND EARLY SCHOOL LEAVING: STRATEGIES FOR AN INCLUSIVE SCHOOL. Giornale Italiano di Educazione alla Salute, Sport e Didattica Inclusiva. 2023. doi:10.32043/gsd.v7i2.851
BibTeX
@article{Chiusaroli2023,
author = {Chiusaroli, Diletta and Vito, Leila De},
title = {DEVIANCE AND EARLY SCHOOL LEAVING: STRATEGIES FOR AN INCLUSIVE SCHOOL},
journal = {Giornale Italiano di Educazione alla Salute, Sport e Didattica Inclusiva},
year = {2023},
doi = {10.32043/gsd.v7i2.851}
}
EUVIMED